ZA200601977B - Cosmetic compositions for imparting skin radiance - Google Patents
Cosmetic compositions for imparting skin radiance Download PDFInfo
- Publication number
- ZA200601977B ZA200601977B ZA200601977A ZA200601977A ZA200601977B ZA 200601977 B ZA200601977 B ZA 200601977B ZA 200601977 A ZA200601977 A ZA 200601977A ZA 200601977 A ZA200601977 A ZA 200601977A ZA 200601977 B ZA200601977 B ZA 200601977B
- Authority
- ZA
- South Africa
- Prior art keywords
- skin
- composition
- particles
- acid
- opacity
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 108
- 239000002537 cosmetic Substances 0.000 title abstract description 14
- 239000002245 particle Substances 0.000 claims abstract description 44
- 239000013078 crystal Substances 0.000 claims abstract description 29
- 229940073609 bismuth oxychloride Drugs 0.000 claims abstract description 22
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 claims abstract description 21
- 239000007787 solid Substances 0.000 claims abstract description 9
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 claims abstract description 8
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229910052582 BN Inorganic materials 0.000 claims abstract description 6
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229910001928 zirconium oxide Inorganic materials 0.000 claims abstract description 6
- 239000007790 solid phase Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 abstract description 6
- 239000006104 solid solution Substances 0.000 abstract description 4
- 241000276425 Xiphophorus maculatus Species 0.000 abstract description 3
- 230000037075 skin appearance Effects 0.000 abstract description 3
- 230000001815 facial effect Effects 0.000 abstract 1
- 239000008247 solid mixture Substances 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 63
- 238000009472 formulation Methods 0.000 description 21
- 239000000463 material Substances 0.000 description 20
- 230000008901 benefit Effects 0.000 description 17
- -1 poly-hydroxy carboxylic acids Chemical class 0.000 description 17
- 239000003795 chemical substances by application Substances 0.000 description 15
- 239000012071 phase Substances 0.000 description 13
- 239000004615 ingredient Substances 0.000 description 9
- 235000004626 essential fatty acids Nutrition 0.000 description 8
- 239000010445 mica Substances 0.000 description 8
- 229910052618 mica group Inorganic materials 0.000 description 8
- 239000003995 emulsifying agent Substances 0.000 description 7
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- 239000003974 emollient agent Substances 0.000 description 5
- 230000003287 optical effect Effects 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 239000002738 chelating agent Substances 0.000 description 4
- 239000003638 chemical reducing agent Substances 0.000 description 4
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 4
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 4
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 4
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 4
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical class NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 3
- NAKFRQULMGLXBT-UHFFFAOYSA-N 6-methoxyquinolin-8-ol Chemical compound N1=CC=CC2=CC(OC)=CC(O)=C21 NAKFRQULMGLXBT-UHFFFAOYSA-N 0.000 description 3
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 3
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 3
- 239000003002 pH adjusting agent Substances 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 229960004889 salicylic acid Drugs 0.000 description 3
- 229920002545 silicone oil Polymers 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 230000000475 sunscreen effect Effects 0.000 description 3
- 239000000516 sunscreening agent Substances 0.000 description 3
- 239000004408 titanium dioxide Substances 0.000 description 3
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 2
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 2
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- GLEVLJDDWXEYCO-UHFFFAOYSA-N Trolox Chemical compound O1C(C)(C(O)=O)CCC2=C1C(C)=C(C)C(O)=C2C GLEVLJDDWXEYCO-UHFFFAOYSA-N 0.000 description 2
- YDONNITUKPKTIG-UHFFFAOYSA-N [Nitrilotris(methylene)]trisphosphonic acid Chemical compound OP(O)(=O)CN(CP(O)(O)=O)CP(O)(O)=O YDONNITUKPKTIG-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 239000008278 cosmetic cream Substances 0.000 description 2
- RCJVRSBWZCNNQT-UHFFFAOYSA-N dichloridooxygen Chemical compound ClOCl RCJVRSBWZCNNQT-UHFFFAOYSA-N 0.000 description 2
- 229940008099 dimethicone Drugs 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 2
- 229940114124 ferulic acid Drugs 0.000 description 2
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 2
- 235000001785 ferulic acid Nutrition 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 229960001679 octinoxate Drugs 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 239000003605 opacifier Substances 0.000 description 2
- 229960001173 oxybenzone Drugs 0.000 description 2
- OSBMVGFXROCQIZ-UHFFFAOYSA-I pentasodium;[bis(phosphonatomethyl)amino]methyl-hydroxyphosphinate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].OP([O-])(=O)CN(CP([O-])([O-])=O)CP([O-])([O-])=O OSBMVGFXROCQIZ-UHFFFAOYSA-I 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- 229960001860 salicylate Drugs 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 2
- 229940116353 sebacic acid Drugs 0.000 description 2
- 239000003352 sequestering agent Substances 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- SAMYFBLRCRWESN-UHFFFAOYSA-N 16-methylheptadecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC(C)C SAMYFBLRCRWESN-UHFFFAOYSA-N 0.000 description 1
- ZUZAETTVAMCNTO-UHFFFAOYSA-N 2,3-dibutylbenzene-1,4-diol Chemical compound CCCCC1=C(O)C=CC(O)=C1CCCC ZUZAETTVAMCNTO-UHFFFAOYSA-N 0.000 description 1
- HWQVXNFIYABVIW-UHFFFAOYSA-N 2-(carboxymethylamino)-4,5-dihydroxypentanoic acid Chemical compound OCC(O)CC(C(O)=O)NCC(O)=O HWQVXNFIYABVIW-UHFFFAOYSA-N 0.000 description 1
- NIONDZDPPYHYKY-UHFFFAOYSA-N 2-hexenoic acid Chemical compound CCCC=CC(O)=O NIONDZDPPYHYKY-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- HXQHFNIKBKZGRP-JRVLCRGASA-N 5,9,12-octadecatrienoic acid Chemical compound CCCCC\C=C\C\C=C\CC\C=C\CCCC(O)=O HXQHFNIKBKZGRP-JRVLCRGASA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- BYMMIQCVDHHYGG-UHFFFAOYSA-N Cl.OP(O)(O)=O Chemical compound Cl.OP(O)(O)=O BYMMIQCVDHHYGG-UHFFFAOYSA-N 0.000 description 1
- 235000013175 Crataegus laevigata Nutrition 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- 229920001273 Polyhydroxy acid Polymers 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- BGNXCDMCOKJUMV-UHFFFAOYSA-N Tert-Butylhydroquinone Chemical compound CC(C)(C)C1=CC(O)=CC=C1O BGNXCDMCOKJUMV-UHFFFAOYSA-N 0.000 description 1
- HXWJFEZDFPRLBG-UHFFFAOYSA-N Timnodonic acid Natural products CCCC=CC=CCC=CCC=CCC=CCCCC(O)=O HXWJFEZDFPRLBG-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 150000001277 beta hydroxy acids Chemical class 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- RICLFGYGYQXUFH-UHFFFAOYSA-N buspirone hydrochloride Chemical compound [H+].[Cl-].C1C(=O)N(CCCCN2CCN(CC2)C=2N=CC=CN=2)C(=O)CC21CCCC2 RICLFGYGYQXUFH-UHFFFAOYSA-N 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940114081 cinnamate Drugs 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000007854 depigmenting agent Substances 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- LNGNZSMIUVQZOX-UHFFFAOYSA-L disodium;dioxido(sulfanylidene)-$l^{4}-sulfane Chemical compound [Na+].[Na+].[O-]S([O-])=S LNGNZSMIUVQZOX-UHFFFAOYSA-L 0.000 description 1
- DUYCTCQXNHFCSJ-UHFFFAOYSA-N dtpmp Chemical compound OP(=O)(O)CN(CP(O)(O)=O)CCN(CP(O)(=O)O)CCN(CP(O)(O)=O)CP(O)(O)=O DUYCTCQXNHFCSJ-UHFFFAOYSA-N 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 239000013020 final formulation Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229960004275 glycolic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000003463 hyperproliferative effect Effects 0.000 description 1
- NBZBKCUXIYYUSX-UHFFFAOYSA-N iminodiacetic acid Chemical class OC(=O)CNCC(O)=O NBZBKCUXIYYUSX-UHFFFAOYSA-N 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 1
- 235000013980 iron oxide Nutrition 0.000 description 1
- VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940089456 isopropyl stearate Drugs 0.000 description 1
- 229940113915 isostearyl palmitate Drugs 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- PJUIMOJAAPLTRJ-UHFFFAOYSA-N monothioglycerol Chemical compound OCC(O)CS PJUIMOJAAPLTRJ-UHFFFAOYSA-N 0.000 description 1
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 108010089741 opacity factor Proteins 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N phosphonic acid group Chemical group P(O)(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- ZPWFUIUNWDIYCJ-UHFFFAOYSA-N propan-2-yl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(C)C ZPWFUIUNWDIYCJ-UHFFFAOYSA-N 0.000 description 1
- BXOLUNAZMVQZQN-UHFFFAOYSA-N propyl 2,3,4-trihydroxybenzoate Chemical compound CCCOC(=O)C1=CC=C(O)C(O)=C1O BXOLUNAZMVQZQN-UHFFFAOYSA-N 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229940035024 thioglycerol Drugs 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M trans-cinnamate Chemical compound [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- VLMWBWYAHNRUGC-UHFFFAOYSA-N tridecyl 2-hydroxybenzoate Chemical compound CCCCCCCCCCCCCOC(=O)C1=CC=CC=C1O VLMWBWYAHNRUGC-UHFFFAOYSA-N 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
- A61K8/0254—Platelets; Flakes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/60—Particulates further characterized by their structure or composition
- A61K2800/65—Characterized by the composition of the particulate/core
- A61K2800/651—The particulate/core comprising inorganic material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
Abstract
A cosmetic skin care composition that can provide the consumer-desired properties of appearance of natural skin radiance, containing solid single-crystal flat platy particles having an Index of Refraction of about 1.8 to about 2.2, the composition having less than 20% Opacity, preferably less than 10% Opacity. The platy particles preferably include bismuth oxy-chloride, aluminum oxide, zirconium oxide, boron nitride, solid solutions and mixtures thereof. A method of imparting radiant skin appearance, especially in the facial area, by applying to the skin the inventive composition is also disclosed.
Description
COSMETIC COMPOSITIONS FOR IMPARTING SKIN RADIANCE
The invention relates to skin care and/or cleansing compositions having flat platy crystalline particles and providing skin radiance.
BACKGROUND OF THE INVENTION w(S)he looks radiant!” is a comment consumers would take as a complement. Skin radiance is lost with age and consumers seek a cosmetic skin care product that would restore or improve the appearance of skin radiance whilst maintaining natural skin tone or color. Specifically, such products should, upon application to the skin: 1) provide a radiant appearance to gkin and 2) provide a colorless or natural skin finish.
Trends in cosmetics have been to use materials, such as mica, - bismuth oxychloride, boron nitride, titanium dioxide, etc., as pigments in nail polish, lipstick, eye shadow, and other cosmetics requiring that the natural skin tone and color be masked. However, these masking cosmetics are not suitable for imparting appearance of radiance and natural glow to the skin. Therefore, it was clear that further work was necessary in order to develop a skin care and/or cleansing product that would perform to the criteria of radiance and natural glow.
The shortcomings of the prior art are overcome with compositions that can provide the consumer-desired optical properties of radiance, without opacifying natural skin color. The present invention includes a skin care and/or cleansing, colorless composition, comprising: (a) 0.01 % to 1 % by weight of the composition of solid single-crystal, flat, plate-like particles; the particles having an index of refraction of about 1.8 to 2.2; and . (pb) a cosmetically acceptable vehicle; such that the composition has an opacity of less than 20 %, preferably less than 10 %.
Examples of suitable single-crystal plate-like particles are bismuth oxychloride, aluminum oxide, boron nitride, zirconium oxide, and/or crystals of solid phase solutions, preferably, bismuth oxychloride.
The plate-like particles have a particle diameter of 10 to 30 microns, and a particle thickness of 0.1 to 5 microns. The plate- like particles comprise 0.05 % to 0.5 % by weight of the skin care and/or cleansing composition, preferably, 0.1 % by weight of the composition. The plate-like particles may be present in a polar solvent prior to incorporation in the composition.
The composition may further contain skin benefit agents, which, when present, are in an amount of at least 0.0001% by weight of the composition. :
Skin benefit agents optionally include retinoids, essential fatty acids, alpha-hydroxy carboxylic acids, beta-hydroxy carboxylic acids, poly-hydroxy carboxylic acids, and mixtures thereof.
Examples of alpha-hydroxy carboxylic acids are glycolic acid, lactic acid, 2-hydroxyoctanoic acid, and mixtures thereof. 2n example of beta-hydroxy carboxylic acid is salicylic acid. Other skin benefit agents include ferulic acid and sebacic acid.
The present invention also includes a method of imparting skin radiance without coloring or opacifying, by applying to the skin the inventive composition.
Except in the operating and comparative examples, Or where otherwise explicitly indicated, all numbers in this description indicating amounte of material or conditions of reaction, physical properties of materials and/or use are to be understood as modified by the word "about." All amounts are by weight of the final composition, unless otherwise specified.
As used herein, the term “comprising” means including, made up of, composed of, consisting and/or consisting essentially of.
The term “leave-on” as used with reference to compositions herein means a composition that is applied to or rubbed on the skin, and left thereon.
The term "skin" as used herein includes the skin on the face (except eye lids and lips), neck, chest, abdomen, back, arms, hands, and legs.
The term “radiance” as used herein means skin glow while maintaining natural looking skin or skin tone, i.e. appearance of natural skin glow.
The term “solid” as used herein means that the material is not fluid at 25°C.
The term “wash-off” as used with reference to compositions herein means a skin cleanser that is applied to or rubbed on the skin and rinsed off substantially immediately subsequent to application.
The inventive compositions and products uniquely create a “radiant” effect on skin without producing a cosmetic appearance. In order to provide the consumer-desired optical properties of skin radiance, the skin care and/or cleansing compositions of the present invention include: (a) 0.01 % to 1 % by weight of the composition of solid single- crystal, flat, plate-like particles; the particles having an index of refraction of 1.8 to 2.2; and (b) a cosmetically acceptable vehicle; such that the final composition has an opacity of less than 20 %, preferably less than 10 %.
The particles are single-crystal and plate-like, such that upon application to skin, the particles impart a natural radiance to the skin. preferred plate-like particles are bismuth oxychloride, aluminum oxide, boron nitride (BN), zirconium oxide, and mixtures thereof. Additionally, crystals of solid phase solutions or mixed crystals may be employed for the purposes of the present invention, as long as they meet the plate-like particle and index of refraction criteria.
The most preferred plate-like particles are bismuth oxychloride, also known as bismuthyl chloride, as they are most 10 readily commercially available.
The product is designed to impart radiance while maintaining natural skin tome, which is achieved by controlling the light transmission properties, or opacity, of the product composition.
The composition may further contain skin benefit agents. Skin benefit agents for the purposes of the present invention include retinoids, essential fatty acids, alpha-hydroxy carboxylic acids, beta-hydroxy carboxylic acids, poly-hydroxy carboxylic acids, and mixtures thereof. Examples of alpha-hydroxy carboxylic acids are glycolic acid, lactic acid, 2-hydroxyoctanoic acid, and mixtures thereof. An example of a beta-hydroxy carboxylic acid is salicylic acid.
The present invention also includes a method of imparting radiant skin appearance, by applying to the skin the inventive composition.
Single-Crystal, Flat, Plate-like Particles
The inventive compositions employ solid particles that are single-crystal, flat and plate-like, to impart a radiant appearance to the skin upon application. By virtue of being flat single crystals, the particles deliver high reflectance.
Flat plate-like crystals can generate this natural radiant appearance through optical reflectance. The ideal properties for the material would be a plate-like crystal habit with dimensions of about 10 to about 30 microns in diameter; about 0.1 to about 5 microns thick, preferably about 0.1 to about 0.5 microns thick; a smooth surface; and an index of refraction of about 1.8 to about 2.2.
Size of the plate-like particles is important because smaller particles reflect too little light to be readily apparent, while larger particles would be visible as discrete objects and thereby provide too much glitter or reflectance. The reflectance (index of refraction) of the plate-like crystal cannot be too high. Too high an index of refraction will inhibit the transmission of natural skin color and create a cosmetic sheen. With too low an index of refraction, the particles will have approximately the same index of refraction as the skin or the product £ilm, resulting in a weak reflectance, thereby diminishing the appearance of radiance.
A single-crystal structure is also key because the smoothness of the crystal surface minimizes opacity or diffuse scattering effects, which would lead to an artificial cosmetic effect. A single-crystal structure maximizes the smooth crystalline surface area. As the facet of a crystal is the smoothest surface possible, it maximizes the degree of reflectance while minimizing the opacity. The product is designed to impart radiance while maintaining natural skin tone, which is achieved by controlling the opacity of the composition.
Suitable solid particles include but are not limited to bismuth oxychloride, aluminum oxide, boron nitride, zirconium oxide, and mixtures thereof. The preferred solid particles are bismuth oxychloride, also known as liquid silver or bismuthyl chloride, because they are readily commercially available. For . example, bismuth oxychloride is sold under the RONA Biron brand from EMD Chemicals Inc., Hawthorne, New Jersey.
Additionally, crystals of solid phase solutions or mixed crystals may be employed for the purposes of the present invention, as long as they meet the plate-like particle and index of refraction criteria. Solid solutions are crystals with impurities dissolved therein, thereby affecting the optical properties of the crystals. The amount of impurities relative to the amount of the crystalline material may be varied to increase or decrease the overall index of refraction of the solid solution plate-like particles according to the present invention, as appropriate. An example of a solid solution is iron rich aluminum oxide, i.e., iron impurities dissolved in aluminum oxide.
The inventive compositions contain about 0.01 % to about 1 % of the golid particles, preferably about 0.05 % to about 0.5 %, and more preferably about 0.1 %, to obtain the best appearance of radiance while maintaining a natural look. The exact amount depends on the final composition and the nature of the other ingredients in the composition.
In the inventive compositions, the solid single crystal plate-like particles are, preferably, dispersed in a polar solvent. If skin benefit agents are included, they are employed in such amounts as to provide a desired skin benefit and yet to not compromise the appearance of radiance.
Index of Refraction of Plate-like Particles
The index of refraction is a measure of the ability of a substrate to bend light incident thereon, and is well known to one skilled in the art. The index of refraction herein is a measure of optical properties the inventive compositions are engineered to achieve, i.e., shine, reflectance, transmission, radiance, glow. Ideally, the index of refraction is about 1.8 to about 2.2. The exemplary suitable materials: bismuth oxychloride, aluminum oxide, zirconium oxide and boron nitride fall within this range; while, in contrast, materials such as mica (1.57), glass (1.5-1.6), titanium dioxide (2.5-2.7) and iron oxides (3.1) lie outside the suitable range of index of refraction.
Opacity of the Composition
The compositions according to the present invention are substantially translucent, so as to be consistent with a natural skin appearance, whilst imparting radiance thereto.
Opacity is a measurement of translucency or opacity.
The inventive skin care and/or cleansing compositions have an opacity of less than about 20 %; preferably less than about 10 %; most preferably, in order to obtain the most desired natural gkin tone or color, less than about 5 %. The opacity of the composition must be in proper balance with the index of refraction of the plate-like particles therein.
Opacity Measurement Protocol
A Hunterlab LabScan XE automated spectrophotometer was used to measure the opacity of product coatings. The coatings were prepared on Leneta Form 2A opacity test charts held in place on a vacuum plate, and an 8-path wet film applicator was used to coat a film with a wet thickness of 2 mils, i.e. 50.8 um (all equipment supplied by Paul N. Gardner Co.). This wet film thickness was chosen by applying 75 pL of composition on about 2 in.?, i.e. 1290 mm?®, which corresponds to a wet film thickness of 58 pum. The coatings were air dried before the opacity measurement.
The opacity values were reported as percent opacity, defined as the Y value of the coating on the black area of the test chart divided by the Y value on the white area times 100%. The Y value is the CIE Tristimulus Y coordinate measured by the
Hunterlab instrument. If a coating were fully transparent, the opacity would be 0%; if fully opaque, it would be 100%.
Skin Benefit Agents
Skin benefit agents may also be optionally, but preferably, included in the compositions of the present invention. Skin benefit agents are defined as active gkin benefit agents other than emollients and other than ingredients that merely improve the physical characteristics of the composition.
Examples of skin benefit agents include retinoids, essential fatty acids, alpha-hydroxy acids, beta-hydroxy acids, polyhydroxy acids, skin lightening agents, and mixtures thereof.
Specific examples of skin benefit agents include retinol, retinoic acid, glycolic acid, lactic acid, 2-hydroxyoctanoic acid, salicylic acid, ferulic acid and sebacic acid, or combinations thereof.
A preferred optional ingredient is selected among essential fatty acids (EFAs). EFAs are fatty acids which are essential for the plasma membrane formation of all cells, in keratinocytes EFA deficiency makes cells hyperproliferative. Supplementation of
EFA corrects this. EFAs also enhance lipid biosynthesis of epidermis and provide lipids for the barrier formation of the 20. epidermis. The essential fatty acids are preferably chosen from linoleic acid, T-linolenic acid, homo-T-linolenic acid, columbinic acid, eicosa-(n-6,9,13)-trienoic acid, arachidonic acid, timnodonic acid, hexaenoic acid and mixtures thereof.
When present, the amount of the skin benefit agent is at least about 0.0001% by weight of the composition.
Other Optional Skin Benefit Materials and Cosmetic Adjuncts
Hydrophobically modified polymeric emulsifiers may be optionally present in the inventive compositions as a co-structurant, typically with a trade name, Pemulen TR series, from 0.001 to 2% by weight, supplied by BF Goodrich Co., Cleveland, OH.
pH adjusting agents may be used to maintain the desired pH, if necessary, especially in the presence of certain acidic actives which may significantly lower the DH of the compositions. preferred pH adjusting agents include inorganic or organic bases guch as ammonium hydroxide, potassium hydroxide, sodium hydroxide and triethanolamine. preferred pH adjusting agents also include inorganic acids such as hydrochloric acid.
Emollient materials (fluid oils) selected from the groupe of silicone oils or synthetic esters may be incorporated into the compositions of the present invention. Oily sunscreens, when used in the composition are considered to be emollient materials, and will be further discussed below.
Silicone oils may be included in the compositions as emollient materials. These are preferably chosen from cyclic or linear polydimethylsiloxanes containing from about 3 to about 9, preferably from about 4 to about 5, silicon atoms. Other silicone oils may be also included, such as polyalkyl siloxanes, polyalkylaryl siloxanes "20 and polyether siloxane copolymers (e.g. dimethicone copolyol). The polyalkyl siloxanes useful herein include, for example, polydimethyl siloxanes with viscosities of from about 5 to about 100,000 centistokes at 25°C, preferably, polydimethyl giloxanes having viscosities from about 10 to about 400 centistokes at 25°C. The oils may be employed singly or in mixtures with one another.
Suitable ester emollients include: esters of fatty acids or alcohols and hydrocarbons, preferably Cs-Cx alkyl ester of fatty acids such as , isopropyl myristate, isopropyl palmitate, isostearyl palmitate, tridecyl salicylate, Ci2-15 octanocate and isopropyl stearate, or any mixtures thereof.
The inventive compositions most preferably further include an ingredient selected from the group consisting of antioxidants, reducing agents, chelating agents, and mixtures thereof to improve the stability of the cosmetic cream. These ingredients provide an additional level of protection against oxidation of skin benefit agents in the cosmetic cream. Common examples of antioxidants, reducing agents and chelating agent for the present formulations can be found in the CTFA International Cosmetic Ingredient Dictionary 4®
Edition, The Cosmetic, Toiletry, and Fragrance Association, Inc., washington, D.C., 1991. preferable reducing agents are sodium sulfite, sodium bisulfite, sodium metabisulfite, sodium thiosulfite or other thiols, such as thioglycerol, thiourea, thioglycolic acid, cysteine and the like. preferable antioxidants are 6-hydroxy- 2.5,7,8-tetra-methylchromane-2-carboxylic acid (trolox), propyl gallate, n-propyl trihydroxybenzoate, t-butyl hydroquinone and butylated hydroxytoluene (BHT), butylated hydroxyanisole (BHA), tocopheryl acetate, ascorbyl palmitate, hydroquinone, dibutyl hydroquinone and the like. :
Suitable examples of chelating agents include, but are not limited to, EDTA, citric acid, tartaric acid, organo aminophosphonic acids and organo phosphonic acid components including certain of the commercially available Dequest™ compounds, marketed by Monsanto.
Preferred is 1-hydroxyethylene-1,1-diphosphonic acid.
Organo aminophosphonic acid is an organic compound having at least one phosphonic acid group, and at least one amino group. Suitable organo aminophosphenic acid components for use herein include the amino alkylene poly (alkylene phosphonic acids) and mnitrilo trimethylene phosphonic acids. Examples of this type of organo aminophosphonic acid components include certain of the commercially available Dequest™ compounds, marketed by Monsanto.
\ preferred are amino tri (methylene phosphonic acid) (Dequest 2006%), diethylene triamine penta (methylene phosphonic acid) and hexamethylene diamine tetra (methylene phosphonic acid) .
Other suitable additional heavy metal ion sequestrants for use herein include nitrilotriacetic acid and polyaminocarboxylic acids such as ethylenediaminotetracetic acid, or ethylenetriamine pentacetic acid.
Still other suitable additional heavy metal ion sequestrants for use herein are iminodiacetic acid derivatives such as 2-hydroxyethyl diacetic acid or glyceryl imino diacetic acid.
Antioxidants are included in the inventive compositions in an amount of from 0.01 to 10%, preferably from 0.1 to 5%, most preferably from 0.2 to 4%. Reducing agents are included in the inventive compositions in an amount of from 0.01 to 10%, preferably from 0.1 to 5%, most preferably from 0.2 to 4%. Chelating agents are included in the inventive compositions in an amount of from 0.01 to 1%, preferably from 0.05 to 0.5%, most preferably from 0.05 to 0.3%.
Sunscreens include those materials commonly employed to block ultraviolet light. Illustrative compounds are the derivatives of para-aminobenzoic acid (PABA), cinnamate and salicylate. For example, octyl methoxycinnamate and 2-hydroxy-4-mnethoxy benzophenone (also known as oxybenzone) can be used. Octyl " methoxycinnamate and 2-hydroxy-4-methoxy benzophenone are commercially available under the trademarks, Parsol MCX and
Benzophenone-3, respectively. The exact amount of sunscreen employed can vary depending upon the degree of protection desired from the sun's UV radiation.
Other optional ingredients may include coloring agents, opacifiers and pigments (e.g. titanium dioxide, silica) and perfumes. Amounts of these materials may range anywhere from 0.001% up to 20% by weight of the composition, and in such a way as to keep the composition within the defined opacity limits.
Use of the Composition
The composition according to the invention is intended primarily as a product for topical application to human skin, especially as an agent for creating or imparting radiance to the skin.
In use, a small quantity of the composition, for example from 1 to Sml, is applied to exposed areas of the skin, from a suitable container or applicator and, if necessary, it is then spread over and/or rubbed into the skin using the hand or fingers or a suitable device.
The compositions may be designed to be left on the skin after application (i.e. leave-on) or washed off (i.e., wash-off or skin cleansing). product Form and Packaging
The composition can be packaged in a suitable container to suit its viscosity and intended use by the consumer. For example, a composition can simply be stored in a non-deformable bottle or squeeze container, such as a tube or a lidded jar. A bottle may be equipped with a pump.
The invention accordingly also provides a closed container containing a cosmetically acceptable composition as herein defined.
The following specific examples further illustrate the invention, but the invention is not limited thereto.
EXAMPLES 1 to 5
Examples of formulations according to the present invention are outlined in table 1.
TABLE 1
Ingredient Trade and CTFAPhase [1 3
Name
Stemricacia |n [1a.5[ia.5]3z.5[17.9(15.7]
Sodium cetearyl sulfate A 1.0 {1.0 |r1.5 [1.5 (Anionic emulsifiers)
Myrj 59 (Nonionic 1.5 2 emulsifiers)
Span 60 {Nonionic 1.5 2 emulsifiers)
Parsol 1789 A Jo.a0] Jo.a [0.4 Jo.2
Bropyl paraben A [0.100.10[0.10 0.10010]
Butylated hydroxtoluene (BAT) A [0.1 Jo.1 Jo.1 fo.1 [0.1
Parsolwx__ [a [0.75] [0.75]0.750.75] bimethicons | Josofo.7s| [0.75]
Bismuth Oxychloride Db [0-10]0.05[0.50 [0.10[0.20
Water |p |BAL* [BAL |BAL* |BAL¥ [BAL¥ mota___ |B lo.0afo.04]0.0470.04]0.04]
Pemulen TR 2 B | Jo.iofo.o5[ Jo.05]
Methyl paraben B [0.150.15 0.15 [0.15]0.15
Sein beserit sgt [Jas [po [po Po [10
Emectant Jc Jo Jo Js [7 [8 port | 100 |100 [200 [100 100 *BAL=Balanced to 100
The formulations presented in Table 1 are prepared in the following fashion. Phase A is heated at 75°C. Phase B is heated to 75°C in a container separate from that of phase A.
Thereafter the phases are combined with mixing with heat being turned off. Phase C is heated to 62°C and mixed into phases
A/B at 62°C. The mixture is cooled until 40°C and then packed.
Phase D may be added in either before or after cooling the mixture.
EXAMPLES 6 - 13
Further examples of formulations according to the present invention are outlined in the table below. The formulations were prepared according to the procedure outlined with reference to the examples above.
TABLE 2
Ingredients Ehase [Examples (wt. %) 6 7 10 11 12 13 acid soap base
Sodium cetearyl 1 1.5 3 sulfate (Anionic emulsifiers)
Myrj 59(Nonionic 2 1 emulsifiers)
Span 60 A 1 (Nonionic emulsifiers)
KOH, 22% (forms |A 2.20 in situ soap with stearic acid)
Bismuth of 0.10 0.10 0.10
Oxychloride
Glycerin B11 1 pj fj fp fb *BAIL=Balanced to 100
EXAMPLE 14
This example illustrates the special advantages of formulating with bismuth oxychloride to achieve skin radiance while maintaining natural skin tone.
The opacity of compositions of the present invention was compared with that of commercial color make-ups that contain bismuth oxychloride. Algo, titanium coated mica was evaluated for its ability to produce a radiant effect in a skin care product upon application to skin, in terms of the opacity of compositions incorporating them. Parameters to focus on are reflectance and opacity of the plate-like material in the base formulations. The reflectance (or the difference in index of refraction) has to be large enough so as to see the effect in base formulation, but low enough as not to be sparkly. In regards to the opacity, the material cannot make the final formulation too opaque {it should be fairly translucent) so as not to create an unnatural appearance.
The ideal materials will have the proper balance between these parameters. A comparison is also made using eye shadow formulations containing plate-like single crystals (bismuth oxychloride) but the formulations are opaque due to other ingredients (opacifiers) present.
A base formulation as shown in the table below was prepared as follows: 1. Heat phase A to 80°C. 2. Heat phase B to 75°C in a separate container. 3. Add phase B to phase A and mix with heat off for 30 min. 4. At 50°C add phase C and mix for 10 min.
Varying amounts of mica and bismuth oxychloride were added to the base formulation, as indicated by the pigment loading in the table below, and the opacity was measured.
TABLE 3 product or Cae toninen vari come [5 [me mmm [5 loi [ FU EN oom weenie clay |n [oe ottrol co 1000 (hem gm [A [02 pemsitioome [a [a0
Er PE PT eens Joa ees fox or = (ooo steams) [A [os mime 9 givceryl dite) [a [os eeisterene a (svesmic sci [a [10
Er A ES
Er FU [CR chenaophenone (pazeol Tas ___[n [30
Polymethyl methacrylate 1.2 (Ganzpearl GMP0820)
Fr GA salicylate)
Material Trade Name Phase wt. % in product
Pecosil PAN 418 (steardiammonium hydroxypropyl panthenyl PE6-7 dimethicone phosphate chloride)
Dequest 2006 (aminotrimethylenephosphonic acid) pps PUR DS ogee Jo los
Er CR
Bismuth oxychloride liquid silver 0.1 (0.1 % loading)
Bismutch oxychloride liquid silver (0.5 % loading)
Methods - The opacity of formulations containing plate-like single crystals (in this case bismuth oxychloride, with a Ds = 16 microns and mica with a Ds; = 22 microns where Ds, means average particle diameter) is determined using a Hunter Lab spectrocolorimeter. The procedure involves making a draw down with the formulation on a black and white draw down card. The opacity factor is determined from the ratio of L values from the black and white background portions of the draw down card.
The formulations studied were 0.1% and 0.5% bismuth oxychloride, 0.5% mica, Almay Bright Eyes Color Cream Shadow
Lilac Luster and its dilution to 40% with isopropanol. The formulations of the base used with the bismuth oxychloride and mica are set forth in the table above. The reflectance was evaluated visually.
Results
The following table contains the opacity results for the formulations and materials studied:
TABLE 6
EC Lo AN oe cS Lc
AIMAY Bright Eyes brand, 97%
Color Cream Shadow, Lilac Luster
The mica formulation exhibited no reflectance from the plate-like crystals (the index of refraction at 1.6 is too low). For bismuth oxychloride (with an index of refraction of ~2.0), the 0.1% formulation showed aesthetically pleasing “radiance” while 0.5% is a little too much (but still falls within limits).
Conclusions
From the results above, the preferred index of refraction range for the plate-like particles is 1.8 to 2.2, as particles with lower values provide very different refractive qualities. If the value is 55 too low, the effect is lost in the formulation (there is no visual distinction between the material and formulation). Too high and the effect will be very shiny and sparkly. The materials (plate-like crystals) added cannot increase/induce opacity in the formulation and give the product an unnatural/cosmetic appearance.
The data above show that the compositions according to the present invention are much less opaque, which permits reflective radiance whilst maintaining a natural, non-cosmetic skin tone color.
Units which are used in this specification and which are not in accordance with the metric system may be converted into the metric system with the aid of the following conversion factor: 1 centistoke = 1x107° m?/s
Amended sheet: 8 March 2007
Claims (6)
1. A skin care or cleansing composition comprising: a) 0.01 % to 1 % by weight of said composition of solid single-crystal, flat, plate-like particles; said particles having an index of refraction of 1.8 to 2.2; and (a) a cosmetically acceptable vehicle; wherein said composition has an opacity of less than about
20%.
2. A composition according to claim 1 having an opacity of less than 10 %.
3. A composition according to claim 1 or claim 2, wherein said plate-like particles are selected from the group consisting of bismuth oxychloride, aluminum oxide, zirconium oxide, boron nitride, crystals of solid phase solutions, and mixtures thereof.
4. A composition according to claim 3, wherein said plate-like particles are bismuth oxychloride.
5. A composition according to any of the preceding claims, wherein said plate-like particles have a particle diameter of 10 to 30 microns.
6. A composition according to any one of the preceding claims, wherein said plate-like particles have a particle thickness of
0.1 to 5 microns.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/682,657 US20050079190A1 (en) | 2003-10-09 | 2003-10-09 | Skin radiance cosmetic compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200601977B true ZA200601977B (en) | 2007-05-30 |
Family
ID=34422576
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200601977A ZA200601977B (en) | 2003-10-09 | 2004-09-20 | Cosmetic compositions for imparting skin radiance |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20050079190A1 (en) |
| EP (1) | EP1675656B1 (en) |
| JP (1) | JP2007533627A (en) |
| CN (1) | CN1863499B (en) |
| AT (1) | ATE533466T1 (en) |
| AU (1) | AU2004283416B2 (en) |
| BR (1) | BRPI0414621A (en) |
| ES (1) | ES2374919T3 (en) |
| MX (1) | MXPA06003560A (en) |
| RU (1) | RU2351309C2 (en) |
| WO (1) | WO2005039522A1 (en) |
| ZA (1) | ZA200601977B (en) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2886853B1 (en) * | 2005-06-14 | 2007-09-28 | Alain Saintrond | COSMETIC AND / OR DERMATOLOGICAL COMPOSITION WITH BORON NITRIDE |
| US20070207101A1 (en) * | 2006-03-01 | 2007-09-06 | General Electric Company | Cosmetic Compositions Comprising Sub-micron Boron Nitride Particles |
| US7476395B2 (en) * | 2006-04-11 | 2009-01-13 | Conopco, Inc. | Cosmetic composition with soft focus properties |
| CN101489522B (en) * | 2006-07-13 | 2011-06-08 | 荷兰联合利华有限公司 | Improved skin lightening cosmetic composition |
| WO2008006739A1 (en) * | 2006-07-13 | 2008-01-17 | Unilever Plc | Improved skin lightening cosmetic composition |
| EP1889598B1 (en) * | 2006-07-18 | 2016-02-03 | L'Oréal | Cosmetic composition in powdered form |
| US7678382B2 (en) * | 2006-12-22 | 2010-03-16 | Conopco, Inc. | Single-crystal platy barium sulfate in cosmetic compositions |
| US20090155321A1 (en) * | 2007-12-12 | 2009-06-18 | Conopco, Inc., D/B/A Unilever | Compositions with encapsulated coloring agents and method to impart a healthy skin appearance |
| US20090155373A1 (en) * | 2007-12-12 | 2009-06-18 | Conopco, Inc., D/B/A Unilever | Cosmetic compositions and method which impart a healthy appearance to skin |
| EP2473153B1 (en) * | 2009-08-31 | 2017-10-25 | Colgate-Palmolive Company | Surface modified pigment |
| EP2473566B1 (en) | 2009-08-31 | 2013-10-16 | Colgate-Palmolive Company | Surface modified pigment |
| CA2786792C (en) * | 2010-01-19 | 2017-01-03 | Elc Management Llc | Composite particles, compositions and methods |
| FR2963735B1 (en) * | 2010-08-16 | 2013-04-05 | Oreal | COSMETIC COUPLEE COMPOSITION |
| FR2967348B1 (en) | 2010-11-17 | 2013-05-10 | Oreal | COSMETIC COMPOSITION FOR EYE CONTOUR |
| WO2012069291A1 (en) | 2010-11-23 | 2012-05-31 | Unilever Nv | Composite particles and compositions with composite particles |
| MX370164B (en) | 2011-08-31 | 2019-12-04 | Natura Cosmeticos Sa | Cosmetic composition intended for making up the skin, cosmetic product and cosmetic use of babassu polysaccharides. |
| WO2013072200A2 (en) | 2011-11-14 | 2013-05-23 | Unilever N.V. | Cosmetic composition |
| JP6321554B2 (en) | 2012-06-21 | 2018-05-09 | ロレアル | Cosmetic composition having pore concealment and long lasting effect |
| CN107002001B (en) | 2014-12-05 | 2020-02-07 | 高露洁-棕榄公司 | Cleansing bar with phenoxyethanol |
| JP6995472B2 (en) | 2016-10-31 | 2022-01-14 | ロレアル | Composition for natural skin lightening effect |
| JP6960806B2 (en) * | 2017-06-30 | 2021-11-05 | ポーラ化成工業株式会社 | Cosmetics |
| RU2667130C1 (en) * | 2017-07-18 | 2018-09-14 | Сергей Рудольфович Утц | Chitosan-containing hydrogel and method of cosmetic skin care with it use |
| CN115551465B (en) | 2020-05-29 | 2024-08-27 | 莱雅公司 | Composition for caring for and/or making up keratin materials |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US500093A (en) * | 1893-06-20 | Machines | ||
| US3718494A (en) * | 1971-03-04 | 1973-02-27 | Du Pont | Sheet-like alpha aluminum oxide |
| LU87030A1 (en) * | 1987-10-28 | 1989-05-08 | Oreal | USE IN COSMETICS OF NEW SUBSTANCES AS INFRARED RADIATION REFLECTORS, COSMETIC COMPOSITIONS CONTAINING THEM AND THEIR USE FOR THE PROTECTION OF THE HUMAN SKIN AGAINST INFRARED RADIATION |
| JPH02184618A (en) * | 1988-12-29 | 1990-07-19 | L'oreal Sa | Infrared reflective transparent cosmetic composition |
| JPH06102609B2 (en) * | 1990-04-24 | 1994-12-14 | 花王株式会社 | Cosmetics |
| FR2664498B1 (en) * | 1990-07-16 | 1993-08-06 | Oreal | PRODUCT BASED ON MINERAL AND ORGANIC LAMELLAR PARTICLES, COMPRISING A MELANIC PIGMENT, ITS PREPARATION METHOD AND ITS USE IN COSMETICS. |
| JP2966913B2 (en) * | 1990-09-20 | 1999-10-25 | 株式会社資生堂 | Base makeup |
| JPH04288010A (en) * | 1991-03-15 | 1992-10-13 | Max Fuakutaa Kk | Cosmetic |
| JPH07101828A (en) * | 1993-09-30 | 1995-04-18 | Toray Ind Inc | Cosmetic |
| RU2110988C1 (en) * | 1995-03-09 | 1998-05-20 | Товарищество с ограниченной ответственностью - Производственно-коммерческая фирма "Линда" | Cosmetic cream |
| DE69634164T2 (en) * | 1995-08-24 | 2005-12-22 | Kinsei Matec Co., Ltd., Osaka | Aluminum oxide particles with increased dispersibility and plasticity and process for their preparation |
| JP3242561B2 (en) * | 1995-09-14 | 2001-12-25 | メルク・ジヤパン株式会社 | Flaky aluminum oxide, pearlescent pigment and method for producing the same |
| FR2745580B1 (en) * | 1996-03-01 | 1998-04-17 | Oreal | COSMETIC COMPOSITION TO BE APPLIED IN PARTICULAR TO LIPS AND USES |
| US6174533B1 (en) * | 1997-05-23 | 2001-01-16 | The Procter & Gamble Company | Skin care compositions and method of improving skin appearance |
| US6482419B1 (en) * | 1998-04-01 | 2002-11-19 | Catalysts & Chemicals Industries Co., Ltd. | Inorganic composite powder and cosmetic comprising the same |
| ATE243018T1 (en) * | 1998-12-22 | 2003-07-15 | Procter & Gamble | TRANSPARENT PERSONAL CARE PRODUCTS |
| US6492326B1 (en) * | 1999-04-19 | 2002-12-10 | The Procter & Gamble Company | Skin care compositions containing combination of skin care actives |
| MXPA01010631A (en) * | 1999-04-19 | 2002-03-14 | Procter & Gamble | Skin care compositions containing combination of skin care actives. |
| US6444647B1 (en) * | 1999-04-19 | 2002-09-03 | The Procter & Gamble Company | Skin care compositions containing combination of skin care actives |
| US6313181B1 (en) * | 1999-05-26 | 2001-11-06 | Color Access, Inc. | Cosmetic compositions containing optical brighteners |
| JP2001053925A (en) * | 1999-08-10 | 2001-02-23 | Matsushita Graphic Communication Systems Inc | Communication controller and serial bus managing device |
| US6558682B2 (en) * | 1999-08-18 | 2003-05-06 | The Procter & Gamble Company | Discontinuous films from skin care compositions |
| US6461626B1 (en) * | 1999-08-18 | 2002-10-08 | The Procter & Gamble Company | Wear resistant topical compositions having improved feel |
| US6514504B1 (en) * | 1999-08-18 | 2003-02-04 | The Procter & Gamble Company | Discontinuous films from skin care compositions |
| JP3673680B2 (en) * | 1999-08-20 | 2005-07-20 | 株式会社コーセー | Makeup cosmetics |
| TWI290472B (en) * | 1999-12-17 | 2007-12-01 | Kao Corp | Cosmetic composition |
| US20030157041A1 (en) * | 2000-01-13 | 2003-08-21 | Dreher John D. | Optical makeup compositon |
| JP2001288039A (en) * | 2000-03-31 | 2001-10-16 | Shiseido Co Ltd | Composition for lip stick |
| JP2001302452A (en) * | 2000-04-17 | 2001-10-31 | Ykk Corp | Cosmetics |
| US6524598B2 (en) * | 2000-07-10 | 2003-02-25 | The Procter & Gamble Company | Cosmetic compositions |
| US6511672B2 (en) * | 2001-01-17 | 2003-01-28 | Color Access, Inc. | Compositions containing optical diffusing pigments |
| DE10153197A1 (en) * | 2001-10-27 | 2003-05-08 | Merck Patent Gmbh | Metallic gloss pigment |
| JP3906072B2 (en) * | 2001-12-20 | 2007-04-18 | キンセイマテック株式会社 | Plate-like alumina particles, cosmetics using the same, and method for producing the same |
| CA2505963C (en) * | 2002-11-15 | 2009-06-02 | Color Access, Inc. | Transparent concealing cosmetic compositions comprising a transparent component and a non-interference platelet |
| US6905696B2 (en) * | 2003-01-06 | 2005-06-14 | Color Access, Inc. | Alignment of enhancers in cosmetic compositions |
-
2003
- 2003-10-09 US US10/682,657 patent/US20050079190A1/en not_active Abandoned
-
2004
- 2004-09-20 CN CN200480029546.4A patent/CN1863499B/en not_active Expired - Fee Related
- 2004-09-20 BR BRPI0414621-2A patent/BRPI0414621A/en not_active IP Right Cessation
- 2004-09-20 AT AT04765497T patent/ATE533466T1/en active
- 2004-09-20 ES ES04765497T patent/ES2374919T3/en not_active Expired - Lifetime
- 2004-09-20 JP JP2006530006A patent/JP2007533627A/en active Pending
- 2004-09-20 RU RU2006115568/15A patent/RU2351309C2/en not_active IP Right Cessation
- 2004-09-20 EP EP04765497A patent/EP1675656B1/en not_active Expired - Lifetime
- 2004-09-20 MX MXPA06003560A patent/MXPA06003560A/en active IP Right Grant
- 2004-09-20 ZA ZA200601977A patent/ZA200601977B/en unknown
- 2004-09-20 AU AU2004283416A patent/AU2004283416B2/en not_active Ceased
- 2004-09-20 WO PCT/EP2004/010633 patent/WO2005039522A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US20050079190A1 (en) | 2005-04-14 |
| AU2004283416A1 (en) | 2005-05-06 |
| AU2004283416B2 (en) | 2007-11-29 |
| ATE533466T1 (en) | 2011-12-15 |
| WO2005039522A1 (en) | 2005-05-06 |
| BRPI0414621A (en) | 2006-11-07 |
| EP1675656B1 (en) | 2011-11-16 |
| RU2006115568A (en) | 2007-11-27 |
| MXPA06003560A (en) | 2006-06-05 |
| CN1863499A (en) | 2006-11-15 |
| JP2007533627A (en) | 2007-11-22 |
| CN1863499B (en) | 2012-11-21 |
| EP1675656A1 (en) | 2006-07-05 |
| RU2351309C2 (en) | 2009-04-10 |
| ES2374919T3 (en) | 2012-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2004283416B2 (en) | Cosmetic compositions for imparting skin radiance | |
| AU652837B2 (en) | Cosmetic compositions | |
| Flick | Cosmetic and Toiletry Formulations, Vol. 3 | |
| US6488917B2 (en) | Optical brighteners as bleaching agents | |
| US6511672B2 (en) | Compositions containing optical diffusing pigments | |
| RU2677664C2 (en) | Cosmetic method for lightening skin and/or lips | |
| JP2001172120A (en) | Composition containing fluorescent substance and specific filler and use thereof | |
| WO2013064367A1 (en) | Cosmetic composition | |
| TW200927185A (en) | Multistep cosmetic compositions | |
| US6979452B2 (en) | Low pH, high skin friction cosmetic creams | |
| EP0688203A1 (en) | Cosmetic composition for artificial tanning of the skin | |
| US20050042187A1 (en) | High skin friction cosmetic creams containing dispersed zinc oxide particles as inorganic sunscreen | |
| US6451330B1 (en) | High skin friction cosmetic creams with retinoids | |
| WO2008104591A2 (en) | Novel cosmetic cream composition comprising c12-c20 fatty acid | |
| CN103889392B (en) | Cosmetic composition | |
| KR20070023626A (en) | Cosmetic composition for imparting skin shine | |
| JP3492966B2 (en) | Cosmetics | |
| JP2018090556A (en) | Makeup cosmetics | |
| JP6829568B2 (en) | Cosmetic composition for skin color correction | |
| JP2003012458A (en) | Makeup cosmetic | |
| AU2004238308A1 (en) | Cosmetic compositions for skin | |
| JP4991166B2 (en) | Cosmetic for decollete | |
| AU745583B2 (en) | Clear cosmetic gel composition | |
| JP2022007124A (en) | Agent for inhibiting diurnal variation of complexion | |
| JP2007238459A5 (en) |